SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $244,000 | -5.4% | 3,259 | -1.5% | 0.04% | +12.5% |
| Q1 2022 | $258,000 | -44.8% | 3,309 | -36.2% | 0.03% | -42.9% |
| Q4 2021 | $467,000 | -1.7% | 5,184 | +1.0% | 0.06% | -11.1% |
| Q3 2021 | $475,000 | +18.5% | 5,132 | -0.5% | 0.06% | +14.5% |
| Q2 2021 | $401,000 | +24.9% | 5,159 | +19.6% | 0.06% | +17.0% |
| Q1 2021 | $321,000 | -3.0% | 4,312 | +122.0% | 0.05% | -11.3% |
| Q4 2020 | $331,000 | +25.9% | 1,942 | +3.8% | 0.05% | +6.0% |
| Q3 2020 | $263,000 | -6.7% | 1,871 | +6.4% | 0.05% | -16.7% |
| Q2 2020 | $282,000 | – | 1,758 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |